other material
confidence high
sentiment neutral
materiality 0.60
Shattuck Labs enters $75M ATM equity distribution agreement with Leerink Partners
Shattuck Labs, Inc.
- Entered Sales Agreement with Leerink Partners for at-the-market offering of up to $75M of common stock.
- Shares sold at market prices; company not obligated to sell any shares.
- Proceeds to fund ongoing/planned clinical trials and for working capital/general corporate purposes.
- Agent commission of up to 3% of gross sales price plus reimbursement of expenses.
- Registration statement on Form S-3 declared effective January 21, 2026; prospectus supplement filed January 22, 2026.